# Intrathecal Hydromorphone for Labor Analgesia

> **NCT02277782** · NA · TERMINATED · sponsor: **Brigham and Women's Hospital** · enrollment: 21 (actual)

## Conditions studied

- Pregnancy

## Interventions

- **DRUG:** Hydromorphone
- **DRUG:** Hyperbaric bupivacaine
- **DRUG:** Fentanyl

## Key facts

- **NCT ID:** NCT02277782
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-09-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Study drug shortage, COVID related suspension of recruitment
- **Last updated:** 2022-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02277782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02277782, "Intrathecal Hydromorphone for Labor Analgesia". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02277782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*